Epitope-focused immunogens targeting the hepatitis C virus glycoproteins induce broadly neutralizing antibodies
Science Advances · 2024
DOI: 10.1126/sciadv.ado2600 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, 2024. Verfasst von Kumar Nagarathinam und 22 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Biochemistry, Center of Structural and Cell Biology in Medicine, University of Lübeck, 23562 Lübeck, Germany. Hauptthemen laut MEDLINE: Hepacivirus, Epitopes, Antibodies, Neutralizing. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 91 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Hepatitis C virus (HCV) infection causes ~290,000 annual human deaths despite the highly effective antiviral treatment available. Several viral immune evasion mechanisms have hampered the development of an effective vaccine against HCV, among them the remarkable conformational flexibility within neutralization epitopes in the HCV antigens. Here, we report the design of epitope-focused immunogens displaying two distinct HCV cross-neutralization epitopes. We show that these immunogens induce a pronounced, broadly neutralizing antibody response in laboratory and transgenic human antibody mice. Monoclonal human antibodies isolated from immunized human antibody mice specifically recognized the grafted epitopes and neutralized four diverse HCV strains. Our results highlight a promising strategy for developing HCV immunogens and provide an encouraging paradigm for targeting structurally flexible epitopes to improve the induction of neutralizing antibodies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Institute of Biochemistry, Center of Structural and Cell Biology in Medicine, University of Lübeck, 23562 Lübeck, Germany.
- Institute of Bioengineering, École Polytechnique Fédérale de Lausanne, Lausanne CH-1015, Switzerland.
- Swiss Institute of Bioinformatics (SIB), Lausanne CH-1015, Switzerland.
- Institute for Experimental Virology, TWINCORE, Centre for Experimental and Clinical Infection Research, a joint venture between the Helmholtz Centre for Infection Research and the Hannover Medical School, 30625 Hannover…
- Institute of Virology, Hannover Medical School, 30625 Hannover, Germany.
- Department of Psychology, University of Lübeck, 23562 Lübeck, Germany.
ORCID-Profile: Kumar Nagarathinam, Andreas Scheck, Luisa J Ströh, Barbora Veselkova, Sarah Tune, Johannes T Cramer, Stéphane Rosset, Sabrina S Vollers, Matthias Ballmaier, Heike Böning, Tanvi Khera, Jonas Obleser, Michael Nassal, Hans-Martin Jäck, Thomas Pietschmann, Bruno E Correia, Thomas Krey
Zitieren
APA
Nagarathinam, K., Scheck, A., Labuhn, M., Ströh, L. J., Herold, E., Veselkova, B., Tune, S., Cramer, J. T., Rosset, S., Vollers, S. S., Bankwitz, D., Ballmaier, M., Böning, H., Roth, E., Khera, T., Ahsendorf-Abidi, H. P., Dittrich-Breiholz, O., Obleser, J., Nassal, M., …, & Krey, T. (2024). Epitope-focused immunogens targeting the hepatitis C virus glycoproteins induce broadly neutralizing antibodies. Science Advances. https://doi.org/10.1126/sciadv.ado2600
Vancouver
Nagarathinam K, Scheck A, Labuhn M, Ströh LJ, Herold E, Veselkova B, et al. Epitope-focused immunogens targeting the hepatitis C virus glycoproteins induce broadly neutralizing antibodies. Science Advances. 2024. doi:10.1126/sciadv.ado2600
BibTeX
@article{Nagarathinam2024,
author = {Nagarathinam, Kumar and Scheck, Andreas and Labuhn, Maurice and Ströh, Luisa J and Herold, Elisabeth and Veselkova, Barbora and Tune, Sarah and Cramer, Johannes T and Rosset, Stéphane and Vollers, Sabrina S and Bankwitz, Dorothea and Ballmaier, Matthias and Böning, Heike and Roth, Edith and Khera, Tanvi and Ahsendorf-Abidi, Henrike P and Dittrich-Breiholz, Oliver and Obleser, Jonas and Nassal, Michael and Jäck, Hans-Martin and Pietschmann, Thomas and Correia, Bruno E and Krey, Thomas},
title = {Epitope-focused immunogens targeting the hepatitis C virus glycoproteins induce broadly neutralizing antibodies},
journal = {Science Advances},
year = {2024},
doi = {10.1126/sciadv.ado2600}
}
EUVIMED